The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles
- Supplementary File 1:
ZIP-Document (ZIP, 692 KiB)
Hempel, N.-J.; Merkl, P.; Knopp, M.M.; Berthelsen, R.; Teleki, A.; Sotiriou, G.A.; Löbmann, K. The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics 2021, 13, 917. https://doi.org/10.3390/pharmaceutics13060917
Hempel N-J, Merkl P, Knopp MM, Berthelsen R, Teleki A, Sotiriou GA, Löbmann K. The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics. 2021; 13(6):917. https://doi.org/10.3390/pharmaceutics13060917
Chicago/Turabian StyleHempel, Nele-Johanna, Padryk Merkl, Matthias M. Knopp, Ragna Berthelsen, Alexandra Teleki, Georgios A. Sotiriou, and Korbinian Löbmann. 2021. "The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles" Pharmaceutics 13, no. 6: 917. https://doi.org/10.3390/pharmaceutics13060917